http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2569619-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45813e6054caadc5a6777adca17c7f69 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-36 |
filingDate | 2010-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62ab5245ce70adf23dff14976d4283a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a54024dcca28cd3d1063603e9e3fb6 |
publicationDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2569619-T3 |
titleOfInvention | Overlapping contiguous peptides for the treatment of birch pollen allergy |
abstract | A composition comprising a plurality of overlapping contiguous peptide fragments comprising a first peptide comprising the sequence from amino acid 2 to amino acids 42-52 of sec. with no. Ident .: 9 where the reactivity of said peptide to the IgE antibodies of the subjects that are allergic to birch pollen is eliminated while the reactivity with T lymphocytes of subjects that are allergic to birch pollen is maintained; a second polypeptide comprising amino acid sequence 42-52 for amino acids 96-131 of sec. with ident no .: 9 where the reactivity of said peptide to the IgE antibodies of the subjects that are allergic to birch pollen is eliminated while the reactivity with T lymphocytes of subjects that are allergic to birch pollen is maintained and a third peptide comprising amino acid sequence 96-131 for amino acid 160 of sec. with ident no .: 9 where the reactivity of said peptide to the IgE antibodies of the subjects that are allergic to birch pollen is eliminated while the reactivity with T lymphocytes of subjects that are allergic to birch pollen is maintained. |
priorityDate | 2009-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.